Evidence map›Paper›PMID 41730675›Full record

ArticleTobacco control2026

Marketing expenditures and industry transformation: are cigarette companies really shifting away from cigarettes?

David T Levy, Nargiz Travis, Michael Cummings

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tobacco control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David T LevyLombardi Comprehensive Cancer Center, Georgetown University Medicical Center, Georgetown University, Washington, DC, USA dl777@georgetown.edu.ORCID http://orcid.org/0000-0001-5280-3612
Nargiz TravisLombardi Comprehensive Cancer Center, Georgetown University Medicical Center, Georgetown University, Washington, DC, USA.ORCID http://orcid.org/0000-0001-6305-8259
Michael CummingsDepartment of Psychiatry and Behavioral Science, School of Medicine, Medical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0002-7103-7017

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
NCI NIH HHS P01 CA200512
6 · The paper itself

Abstract

introductionCigarette companies have stated their intent to transition from selling cigarettes to selling less harmful products, such as e-cigarettes. We examine trends in US cigarette marketing expenditures and their relationship to e-cigarette use.

methodsWe obtained US cigarette marketing expenditures data for 2010-2022 from the 2022 Federal Trade Commission Cigarette Report. We compared these expenditures to adult e-cigarette prevalence data from the National Health Interview Survey (NHIS). We also considered types of marketing expenditures.

resultsCigarette marketing expenditures per pack have increased since 2010, most of which involve price discounting. These increases co-occurred with increased e-cigarette use, especially among youth and young adults.

conclusionsOur analysis finds that, despite declining cigarette sales, cigarette companies have intensified their marketing efforts by allocating increasing expenditures per pack as e-cigarette use increased.

Indexed as

Advertising and PromotionElectronic nicotine delivery devicesSurveillance and monitoringTobacco industry

Identifiers

PMID41730675
PMCPMC13428996

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.